Significant Pain Reduction
Sun J et al. reported that ESWT was significantly more likely than placebo to relieve chronic plantar fasciitis pain, with OR 2.58 across 9 RCTs and 935 patients.
Sun J et al., 2017, Medicine (LWW)
RESEARCH & EVIDENCE
The Clinical Evidence Behind Shockwave Therapy
19 peer-reviewed studies. Meta-analyses spanning thousands of patients. The science MyoAxis treatment plans are built on.
Shockwave therapy (Extracorporeal Shock Wave Therapy, or ESWT) has been studied extensively across orthopedic and sports medicine literature. The evidence below covers plantar fasciitis, tennis elbow, calcific tendinitis, chronic tendinopathy, and bone non-union — the conditions we treat at MyoAxis. Every protocol we use is grounded in this research.
What the Research Tells Us
Effective for Chronic Tendinopathy
Hosseini SK et al. found clinically meaningful pain reduction across plantar fasciitis, lateral epicondylitis, and rotator cuff tendinopathy in a 45-RCT meta-analysis.
Hosseini SK et al., 2024, BMC Sports Science, Medicine and Rehabilitation
Comparable to Surgery, Without the Complications
Cacchio A et al. reported 70.7% union with ESWT versus 73% with surgery for hypertrophic non-union, with 0% adverse events in the ESWT group versus 7% complications in surgery.
Cacchio A et al., 2024, PMC
The Biological Mechanisms Behind ESWT
Shockwave therapy is not just about pain relief. The mechanism literature in this bibliography describes specific cellular responses that help explain why chronic tendon, fascia, and bone problems may respond after standard rest-based care has stalled.
VEGF Upregulation
Shockwave triggers vascular endothelial growth factor expression, increasing blood flow to damaged tissue. This mechanism is described in tendon and bone-healing reviews.
See: Frontiers in Veterinary Science review authors, 2022; Frontiers in Endocrinology review authors, 2023
eNOS Activation
Endothelial nitric oxide synthase activation supports vascular healing and inflammation modulation. Notarnicola A et al. linked ESWT-related eNOS and VEGF increases with angiogenesis in treated tendons.
See: Notarnicola A et al., 2012
Mesenchymal Stem Cell Recruitment
Acoustic pressure waves recruit MSCs to the injury site, accelerating repair. A 2024 review in Stem Cell Research & Therapy found ESWT enhanced MSC proliferation, differentiation, migration, and recruitment.
See: Stem Cell Research & Therapy review authors, 2024
Collagen Synthesis & Osteogenesis
ESWT stimulates collagen production in tendons and osteogenic activity in bone, supporting structural recovery. Tendon evidence centers on TGF-beta1 and collagen, while bone evidence centers on BMP, VEGF, and osteoblast signaling.
See: Notarnicola A et al., 2012; Frontiers in Endocrinology review authors, 2023
Conditions With Strongest Research Support
The strength of evidence varies by diagnosis, study design, and treatment protocol. The conditions below have the most robust support in the PDF bibliography and are the conditions MyoAxis evaluates most carefully before recommending ESWT.
Plantar Fasciitis
Plantar fasciitis has the strongest evidence in the PDF, including multiple meta-analyses and a GRADE review. Sun J et al. found ESWT was 2.58 times more likely than placebo to produce pain relief.
Sun J et al., 2017; Charles R et al., 2023
Tennis Elbow (Lateral Epicondylitis)
The PDF cites a 13-RCT review of 1,035 patients showing significant pain and grip-strength improvement, plus a 2024 double-blind RCT where focused ESWT outperformed ultrasound and placebo.
Xu et al., 2020; Scientific Reports trial authors, 2024
Calcific Tendinitis of the Shoulder
The PDF notes FDA-cleared indications including calcific shoulder tendinitis and includes upper-limb and rotator cuff tendinopathy evidence. Rotator cuff studies support pain reduction and neovascularization when modality is matched to tissue depth.
Frontiers in Medicine review authors, 2024; Li C et al., 2021
Chronic Achilles Tendinopathy
Achilles evidence is meaningful but more variable than plantar fasciitis. The GRADE review rated Achilles and patellar tendinopathy evidence as moderate.
Charles R et al., 2023; International Journal of Research in Medical Sciences review authors, 2025
Patellar Tendinopathy (Jumper's Knee)
Patellar tendinopathy is supported by moderate evidence in the GRADE review and by broader tendinopathy RCT literature. The PDF emphasizes protocol optimization as a reason results vary across studies.
Charles R et al., 2023; Hosseini SK et al., 2024
Bone Non-Union & Stress Fractures
The bone-healing literature includes systematic reviews, an RCT comparing ESWT with surgery, and a case series in runners. Reported union rates were about 72-73% in non-union literature, with ESWT showing fewer complications than surgery in one RCT.
Journal of Clinical Medicine review authors, 2022; Cacchio A et al., 2024; Sports Medicine case series authors, 2023
Landmark Studies
Sun J et al. · 2017 · Medicine (LWW)
ESWT vs. Placebo for Chronic Plantar Fasciitis: Meta-Analysis
Meta-analysis of randomized controlled trials, 9 RCTs, 935 patients
ESWT produced significantly higher pain relief than placebo, with an odds ratio of 2.58 and a 95% confidence interval of 1.97-3.39. Focused shockwave showed the strongest evidence in this analysis.
What This Means For Patients: For chronic plantar fasciitis, shockwave was more likely than placebo to produce meaningful pain relief.
Hosseini SK et al. · 2024 · BMC Sports Science, Medicine and Rehabilitation
ESWT for Pain Across Multiple Tendinopathies: 45-Study Meta-Analysis
Meta-analysis of randomized controlled trials, 45 clinical RCTs
Shockwave therapy reduced pain across plantar fasciitis, lateral epicondylitis, and rotator cuff tendinopathy. Reported effect sizes were clinically meaningful, including SMD 1.63 for plantar fasciitis, 1.21 for lateral epicondylitis, and 0.88 for rotator cuff tendinopathy.
What This Means For Patients: ESWT has evidence across several tendon regions, not just one isolated diagnosis.
Xu et al. · 2020 · American Journal of Sports Medicine / PMC
ESWT for Lateral Epicondylitis (Tennis Elbow): 13-RCT Review
Systematic review of randomized controlled trials, 13 RCTs, 1,035 patients
The review found significant improvements in VAS pain and grip strength compared with controls. Benefits were reported across both focused and radial shockwave modalities.
What This Means For Patients: For tennis elbow, ESWT may improve both pain and measurable hand strength.
Cacchio A et al. · 2024 · PMC
ESWT vs. Surgery for Hypertrophic Non-Union: RCT
Randomized controlled trial, Not reported in PDF
At 6 months, union rates were 70.7% for ESWT and 73% for surgery. The ESWT group had zero adverse events, while the surgical group had a 7% complication rate.
What This Means For Patients: In this fracture subtype, ESWT approached surgical union rates with fewer reported complications.
Translating Research Into Care
The evidence informs how MyoAxis structures shockwave protocols, including visit frequency, treatment intensity, session count, condition selection, and how progress is measured. For example, plantar fasciitis and tennis elbow protocols draw from RCT and meta-analysis data, while bone-healing cases require different screening and expectations.
There is a real gap between research and clinical practice. Many providers offer shockwave therapy, but the parameters may not match the diagnosis, tissue depth, or treatment windows used in the validated studies. MyoAxis uses the evidence to decide whether ESWT fits the case before recommending it.
Patients should ask any provider, including MyoAxis, what evidence supports the plan. A confident provider should be able to name the diagnosis, explain why shockwave is appropriate, and cite specific studies or protocols rather than relying on generic claims.
Bibliography — All 19 Studies
1. Sun J, et al. ESWT vs. placebo for chronic plantar fasciitis: meta-analysis. Medicine (LWW). 2017.
Meta-analysis of randomized controlled trials; 9 RCTs, 935 patients; condition: Plantar fasciitis.
2. Journal of Foot & Ankle Surgery review authors. ESWT vs. multiple conservative treatments for plantar fasciitis. Journal of Foot & Ankle Surgery. 2024.
Systematic review and meta-analysis of randomized controlled trials; 15 RCTs, 1,123 patients; condition: Plantar fasciitis.
3. Hosseini SK, et al. ESWT for pain across multiple tendinopathies: 45-study meta-analysis. BMC Sports Science, Medicine and Rehabilitation. 2024.
Meta-analysis of randomized controlled trials; 45 clinical RCTs; condition: Multiple tendinopathies.
4. Xu, et al. ESWT for lateral epicondylitis (tennis elbow): 13-RCT review. American Journal of Sports Medicine / PMC. 2020.
Systematic review of randomized controlled trials; 13 RCTs, 1,035 patients; condition: Tennis elbow / lateral epicondylitis.
5. Charles R, et al. ESWT for plantar fasciitis, Achilles and patellar tendinopathy: GRADE review. Frontiers in Immunology. 2023.
GRADE-quality evidence review; Not reported in PDF; condition: Plantar fasciitis, Achilles tendinopathy, patellar tendinopathy.
6. Frontiers in Medicine review authors. ESWT for upper limb tendinopathies: systematic review of RCTs. Frontiers in Medicine. 2024.
Multi-database systematic review of randomized controlled trials; Not reported in PDF; condition: Upper limb tendinopathies.
7. Scientific Reports trial authors. Focused shockwave vs. ultrasound therapy for tennis elbow: RCT. Scientific Reports. 2024.
Double-blind randomized controlled trial; 60 patients; condition: Tennis elbow / lateral epicondylitis.
8. Frontiers in Veterinary Science review authors. Biological response of ESWT to tendinopathy in vivo: systematic review. Frontiers in Veterinary Science. 2022.
Comprehensive systematic review; Not reported in PDF; condition: Tendinopathy mechanisms.
9. Notarnicola A, et al. Biological effects of ESWT on tendon tissue: TGF-beta1 and collagen synthesis. Muscles, Ligaments and Tendons Journal. 2012.
In vitro and in vivo biological study; Not reported in PDF; condition: Tendon tissue healing.
10. International Journal of Research in Medical Sciences review authors. ESWT for tendinopathies: comprehensive literature review. International Journal of Research in Medical Sciences. 2025.
Comprehensive literature review of randomized controlled trials; 4 RCTs, 432 patients; condition: Plantar fasciitis, Achilles tendinopathy, lateral epicondylitis, patellar tendinopathy.
11. Li C, et al. Radial vs. focused ESWT for non-calcific rotator cuff tendinopathy: RCT. BioMed Research International. 2021.
Randomized controlled trial; Not reported in PDF; condition: Non-calcific rotator cuff tendinopathy.
12. MedRxiv review authors. ESWT and wound healing: tissue regeneration across 47 clinical studies. MedRxiv. 2025.
Systematic review; 47 studies; condition: Wound and soft-tissue healing.
13. Stem Cell Research & Therapy review authors. ESWT recruits and activates the body's own mesenchymal stem cells. Stem Cell Research & Therapy. 2024.
Comprehensive peer-reviewed review; Not reported in PDF; condition: Mesenchymal stem cell recruitment and tissue repair.
14. Journal of Clinical Medicine review authors. ESWT for non-union in long bones: systematic review and meta-analysis. Journal of Clinical Medicine. 2022.
Systematic review and meta-analysis; 1,200 long bone non-unions; condition: Long bone non-union.
15. Rutten S, et al. ESWT in fracture management: systematic review of union rates. Clinical Orthopaedics / PMC. 2024.
Multi-study systematic review; 11 eligible studies; condition: Non-unions, delayed unions, acute high-energy fractures.
16. Cacchio A, et al. ESWT vs. surgery for hypertrophic non-union: RCT. PMC. 2024.
Randomized controlled trial; Not reported in PDF; condition: Hypertrophic non-union.
17. Frontiers in Endocrinology review authors. Mechanisms of ESWT in fracture healing: growth factor analysis. Frontiers in Endocrinology. 2023.
Narrative review; Not reported in PDF; condition: Fracture healing and osteogenesis.
18. Sports Medicine case series authors. ESWT for bone stress injuries in runners: return-to-sport outcomes. Sports Medicine / PMC. 2023.
Case series; 40 runners; condition: Bone stress injuries and stress fractures.
19. PM&R Journal review authors. ESWT for bone pathologies: 53-study systematic review, 1,835 patients. PM&R Journal. 2025.
Systematic review with Oxford evidence grading; 53 studies, 1,835 patients; condition: Fractures, osteonecrosis, medial tibial stress syndrome, bone marrow edema syndrome.
Research FAQs
Is shockwave therapy backed by science?
Yes. The studies summarized on this page include randomized controlled trials, systematic reviews, meta-analyses, and biological mechanism reviews. The strongest clinical evidence in this bibliography supports ESWT for plantar fasciitis, lateral epicondylitis, selected tendinopathies, and selected bone-healing problems.
How many studies have been done on shockwave?
This MyoAxis evidence library summarizes 19 peer-reviewed clinical and mechanism studies from the local PDF review. Several of those papers are themselves large reviews, including a 45-RCT tendinopathy meta-analysis, a 53-study bone-pathology review, and plantar fasciitis meta-analyses spanning more than 900 and 1,100 patients.
What conditions have the strongest evidence for shockwave therapy?
The strongest evidence in this bibliography is for plantar fasciitis, tennis elbow, chronic tendinopathy, and selected fracture non-unions. Plantar fasciitis has multiple large RCT-based reviews, while tennis elbow has a 13-RCT review of 1,035 patients and a 2024 double-blind RCT.
Is shockwave better than cortisone injections?
For plantar fasciitis, the 2024 Journal of Foot & Ankle Surgery systematic review cited in the PDF reported better functional outcomes versus corticosteroid injection at 24 weeks. That does not mean ESWT is better for every patient or every diagnosis, but it supports considering shockwave before repeated injections in appropriate chronic cases.
How does shockwave therapy work biologically?
The mechanism studies in this bibliography describe VEGF upregulation, eNOS activation, angiogenesis, collagen synthesis through TGF-beta1 signaling, mesenchymal stem cell recruitment, and osteogenic growth-factor activity. In plain language, ESWT appears to stimulate repair signaling in tissue that has stopped healing normally.
Are there any conditions where shockwave doesn't help?
The evidence is not equally strong for every diagnosis. The PDF notes that Achilles and patellar tendinopathy evidence is moderate and more variable, often because protocols differ between studies. A good provider should screen diagnosis, tissue irritability, chronicity, contraindications, and whether ESWT is actually the right tool.
How do I know my provider is using evidence-based shockwave protocols?
Ask which diagnosis the provider is treating, what study or protocol supports the treatment plan, which modality is being used, and how response will be measured. The studies on this page show that outcomes depend on condition selection, dosage, tissue depth, and follow-up timing, not simply owning a shockwave device.
Evidence-Based Care in Jersey City
If you've been told "just rest" or offered injections without exploring shockwave — you may be missing a treatment with significant research support. Book a consultation and we'll review whether the evidence supports ESWT for your specific case.